Larimar Therapeutics, Inc. · NASDAQ:LRMR
BlackRock, Inc. reported a 5.10% stake in Larimar Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 4, 2025
BlackRock, Inc. reported a 5.10% stake in Larimar Therapeutics, Inc., 3,265,905 shares, as a passive investor on Dec 31, 2024. Filed Feb 4, 2025 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 3,265,905
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.10% | 3,265,905 |
Source
Related
- Larimar Therapeutics, Inc.
- BlackRock, Inc.
- Larimar Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 22, 2025
- Form 4 · Harlow John B. Jr. · Oct 1, 2026
- Form 4 · Hamilton Thomas Edward · Jul 8, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · May 14, 2026
- Schedule 13G/A · Millennium Management LLC · Apr 30, 2026
- Schedule 13D/A · Deerfield Management Company, L.P. · Mar 2, 2026